The Centers for Disease Control and Prevention recently announced that 33 deaths have been attributed to a pulmonary disease seemingly caused by vaping. Nearly everyone who has died from the disease, and many who have been sick, used a black market THC product, which could be a call for companies to bolster their supply chains and fill out their in-house legal departments.

“A lot of these companies are really startups. When you’re a startup, you’re mostly a skeleton crew and you outsource legal services when you need it,” said Robert DiPisa, co-chair of the cannabis law group at Cole Schotz in its New Jersey and New York offices. “I think you’re going to see these cannabis companies build out their in-house legal counsel. I think what’s happening in the vaping industry might act as a catalyst for vaping companies to bulk up their in-house legal counsel.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]